G29-67328-55328
2 vaccinations
1 coded response
21 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 967 / HI
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Dose 1 — Pfizer-BioNTech
-
2021-03-09
Registered in v-safe
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-14
- 2021-03-15
- 2021-03-22
- 2021-03-31
- 2021-04-07
- 2021-04-12
- 2021-04-19
- 2021-06-07
-
2021-08-24
Dose 2 — Pfizer-BioNTech
- 2021-09-06
- 2021-09-07
- 2021-09-14
- 2021-09-21
- 2021-09-28
- 2021-10-06
-
2021-11-23
Survey response — 3 months, dose 2MedDRA: Influenza, Nasopharyngitis — Feeling: PoorFree text: Cold flu symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-02-25
- 2022-08-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Pfizer-BioNTech | |
| 2 | 2021-08-24 | Pfizer-BioNTech | No |
Free text
Release 10 — 3 months, dose 2
Symptoms: Cold flu symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release